Menna-Allah Elaskandrany, DO1, Mohamed Ismail, DO2, Michael Farber, DO3, Michael Bebawy, DO2, Sameer Rao, MBBS2, Mahinaz Mohsen, MD2, Rohan Karkra, MBBS2, Brian Kim, MD4, Muhammad Hassaan Arif Maan, MBBS2, Weizheng Wang, MD2 1Lenox Hill Hospital, Northwell Health, New York, NY; 2Rutgers New Jersey Medical School, Newark, NJ; 3New York Institute of Technology College of Osteopathic Medicine, Glen Head, NY; 4Rutgers New Jersey Medical School, Kearny, NJ Introduction: Racial and socioeconomic disparities are well-documented in both cardiovascular disease and inflammatory bowel disease (IBD), yet their intersection remains underexplored. This study examines how the prevalence of coronary artery disease (CAD) varies by race and household income among hospitalized patients with IBD, utilizing a national database. Methods: We analyzed 4,142,365 IBD-related hospitalizations from the National Inpatient Sample (2016–2019), stratifying patients by CAD status. Race categories included White, Black, Hispanic, Asian/Pacific Islander, Native American, and Other. Socioeconomic status was assessed by national median household income quartile (0–25th, 26–50th, 51–75th, 76–100th). Proportional differences were described. Results: Among patients with IBD and concomitant CAD (n = 842,658), 76.9% were White (n = 647,850), compared to 70.3% of those without CAD (n = 2,318,442). Black patients comprised 11.6% (n = 97,747) of the CAD group as compared to 14.7% (n = 485,062) of the non-CAD group. Hispanic patients made up 6.9% (n = 58,144) of the CAD group versus 9.6% (n = 316,772) in the non-CAD group. Similarly, Asian/Pacific Islander patients made up 1.8% of the CAD group versus 2.2% of the non-CAD group, while Native American patients made up 0.4% of the CAD group versus 0.5% of the non-CAD group.
By income, 29.5% (n = 248,584) the patients with CAD were from the lowest income quartile (0–25th) compared to 28.5% (n = 940,416) of non-CAD patients. Only 19.9% (n = 167,689) of CAD patients were from the highest income quartile (76–100th), as compared to 21.4% (n = 706,137) of non-CAD patients. Discussion: CAD among hospitalized patients with IBD is disproportionately prevalent in White patients and those from lower-income quartiles. These disparities may reflect unequal access to preventive care, cumulative exposure to social determinants of health, structural barriers to early cardiovascular risk management, and genetic predisposition. Our findings highlight the need for equity-focused interventions to reduce cardiovascular risk in underrepresented IBD populations. Improved access to preventive care and socioeconomic support may help close these gaps in cardiovascular outcomes among patients with IBD.
Figure: Demographic Disparities in Coronary Artery Disease Among Hospitalized Patients with Inflammatory Bowel Disease: Race and Income Distributions
Figure: Demographic Disparities in Coronary Artery Disease Among Hospitalized Patients with Inflammatory Bowel Disease: Race and Income Distributions
Disclosures: Menna-Allah Elaskandrany indicated no relevant financial relationships. Mohamed Ismail indicated no relevant financial relationships. Michael Farber indicated no relevant financial relationships. Michael Bebawy indicated no relevant financial relationships. Sameer Rao indicated no relevant financial relationships. Mahinaz Mohsen indicated no relevant financial relationships. Rohan Karkra indicated no relevant financial relationships. Brian Kim indicated no relevant financial relationships. Muhammad Hassaan Arif Maan indicated no relevant financial relationships. Weizheng Wang indicated no relevant financial relationships.
Menna-Allah Elaskandrany, DO1, Mohamed Ismail, DO2, Michael Farber, DO3, Michael Bebawy, DO2, Sameer Rao, MBBS2, Mahinaz Mohsen, MD2, Rohan Karkra, MBBS2, Brian Kim, MD4, Muhammad Hassaan Arif Maan, MBBS2, Weizheng Wang, MD2. P3348 - Racial and Socioeconomic Disparities in Coronary Artery Disease Prevalence Among Hospitalized Patients With Inflammatory Bowel Disease, ACG 2025 Annual Scientific Meeting Abstracts. Phoenix, AZ: American College of Gastroenterology.
